Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,061.60
+27.00 (2.61%)
At close: Jun 3, 2025, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 126.87 billion as of June 3, 2025. Its market cap has increased by 27.29% in one year.
Market Cap
126.87B
Enterprise Value
121.95B
Revenue
23.87B
Ranking
n/a
PE Ratio
26.18
Stock Price
1,061.60
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 126.87B, an increase of 38.34%. That is a compound annual growth rate of 8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 126.87B | 5.28% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,025.12B |
| Divi's Laboratories | 1,755.28B |
| Cipla | 1,183.76B |
| Mankind Pharma | 1,018.35B |
| Apollo Hospitals Enterprise | 989.31B |
| Zydus Lifesciences | 935.80B |
| Aurobindo Pharma | 666.64B |
| Alkem Laboratories | 609.60B |